Health-Related Quality of Life in Patients Receiving Reduced-Intensity Conditioning Allogeneic Hematopoietic Stem Cell Transplantation

Bone Marrow Transplantation - United Kingdom
doi 10.1038/sj.bmt.1705406
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Reduced-Intensity Conditioning Allogeneic Hematopoietic Cell Transplantation in Adults With Acute Myeloid Leukemia

Cancer Control
MedicineOncologyHematology
2011English

Incidence and Outcomes of Primary Engraftment Failure in Patients Undergoing Reduced Intensity Conditioning Allogeneic Hematopoietic Stem Cell Transplantation for Primary Myelofibrosis

Biology of Blood and Marrow Transplantation
TransplantationHematology
2016English

A Reduced-Intensity Conditioning Regimen for Patients With Dyskeratosis Congenita Undergoing Hematopoietic Stem Cell Transplantation

Biology of Blood and Marrow Transplantation
TransplantationHematology
2016English

Achieving Stringent CR Is Essential Before Reduced-Intensity Conditioning Allogeneic Hematopoietic Cell Transplantation in AML

Bone Marrow Transplantation
TransplantationHematology
2013English

Outcomes of Reduced Intensity Conditioning Allogeneic Hematopoietic Cell Transplantation Performed in the Inpatient Versus Outpatient Setting

Biology of Blood and Marrow Transplantation
TransplantationHematology
2019English

Long-Term Results of Allogeneic Hematopoietic Stem Cell Transplantation After Reduced-Intensity Conditioning With Busulfan, Fludarabine, and Antithymocyte Globulin

Neoplasma
Cancer Research
2011English

The Current Status of Reduced-Intensity Allogeneic Hematopoietic Stem Cell Transplantation for Multiple Myeloma

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2006English

Reduced-Intensity Allogeneic Hematopoietic Cell Transplantation Using Fludarabine–melphalan Conditioning for Treatment of Mature T-Cell Lymphomas

Bone Marrow Transplantation
TransplantationHematology
2011English

Improvement in Health-Related Quality of Life for Sickle Cell Disease Patients Treated With Chemotherapy-Free Allogeneic Hematopoietic Stem-Cell Transplantation: A Pilot Study

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy